| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/22/2023 | 6.51% | UBS | $11 → $9 | Maintains | Neutral |
| 10/31/2023 | 30.18% | Raymond James | $12 → $11 | Maintains | Strong Buy |
| 10/04/2023 | 42.01% | Raymond James | $18 → $12 | Maintains | Strong Buy |
| 09/18/2023 | 24.26% | Citigroup | $10.5 → $10.5 | Maintains | Neutral |
| 08/01/2023 | 113.02% | Raymond James | $20 → $18 | Maintains | Strong Buy |
| 07/24/2023 | 136.69% | Raymond James | $21 → $20 | Maintains | Strong Buy |
| 07/05/2023 | 24.26% | Morgan Stanley | $19 → $10.5 | Maintains | Overweight |
| 06/28/2023 | 0.59% | Citigroup | → $8.5 | Reiterates | Neutral → Neutral |
| 05/19/2023 | 6.51% | Credit Suisse | $15 → $9 | Maintains | Neutral |
| 05/09/2023 | 0.59% | Goldman Sachs | $11 → $8.5 | Maintains | Neutral |
| 05/05/2023 | 148.52% | Raymond James | $23 → $21 | Maintains | Strong Buy |
| 04/17/2023 | 18.34% | UBS | $19 → $10 | Downgrades | Buy → Neutral |
| 04/11/2023 | 30.18% | Goldman Sachs | $15.5 → $11 | Maintains | Neutral |
| 04/10/2023 | 30.18% | Goldman Sachs | $15.5 → $11 | Downgrades | Buy → Neutral |
| 02/01/2023 | — | Wolfe Research | Downgrades | Outperform → Peer Perform | |
| 01/27/2023 | 89.35% | Goldman Sachs | $14 → $16 | Maintains | Buy |
| 01/20/2023 | 172.19% | Raymond James | $25 → $23 | Maintains | Strong Buy |
| 11/08/2022 | 53.85% | Goldman Sachs | $15 → $13 | Maintains | Buy |
| 11/04/2022 | 195.86% | Raymond James | $30 → $25 | Maintains | Strong Buy |
| 10/20/2022 | 255.03% | Raymond James | $31 → $30 | Maintains | Strong Buy |
| 10/19/2022 | 77.51% | Goldman Sachs | $20 → $15 | Maintains | Buy |
| 07/22/2022 | 266.86% | Raymond James | $35 → $31 | Maintains | Strong Buy |
| 07/06/2022 | 124.85% | Morgan Stanley | $21 → $19 | Maintains | Overweight |
| 06/14/2022 | 148.52% | Morgan Stanley | $22.5 → $21 | Maintains | Overweight |
| 05/19/2022 | 166.27% | Morgan Stanley | $23 → $22.5 | Maintains | Overweight |
| 05/06/2022 | 314.2% | Raymond James | $32 → $35 | Maintains | Strong Buy |
| 04/26/2022 | 278.7% | Raymond James | $38 → $32 | Maintains | Strong Buy |
| 04/19/2022 | 172.19% | Morgan Stanley | $25 → $23 | Maintains | Overweight |
| 04/05/2022 | 195.86% | Goldman Sachs | → $25 | Initiates Coverage On | → Buy |
| 03/10/2022 | 231.36% | Wolfe Research | $44 → $28 | Maintains | Outperform |
| 03/03/2022 | 195.86% | Morgan Stanley | $23.75 → $25 | Maintains | Overweight |
| 02/25/2022 | 349.7% | Raymond James | $35 → $38 | Maintains | Strong Buy |
| 01/21/2022 | 314.2% | Raymond James | $31 → $35 | Maintains | Strong Buy |
| 12/01/2021 | 181.07% | Morgan Stanley | $21.75 → $23.75 | Maintains | Overweight |
| 11/22/2021 | 266.86% | Raymond James | → $31 | Upgrades | Outperform → Strong Buy |
| 11/05/2021 | 266.86% | Raymond James | $24 → $31 | Maintains | Outperform |
| 10/22/2021 | 184.02% | Raymond James | $23 → $24 | Maintains | Outperform |
| 09/22/2021 | 157.4% | Morgan Stanley | $19 → $21.75 | Maintains | Overweight |
| 08/06/2021 | 172.19% | Raymond James | $20 → $23 | Maintains | Outperform |
| 08/06/2021 | 160.36% | Credit Suisse | $20 → $22 | Maintains | Outperform |
| 07/06/2021 | 124.85% | Morgan Stanley | $18.5 → $19 | Maintains | Overweight |
| 06/15/2021 | 219.53% | Wolfe Research | → $27 | Initiates Coverage On | → Outperform |
| 05/17/2021 | 95.27% | B of A Securities | → $16.5 | Downgrades | Neutral → Underperform |
| 05/12/2021 | 136.69% | Credit Suisse | $19 → $20 | Maintains | Outperform |
| 05/07/2021 | 136.69% | Raymond James | $19 → $20 | Maintains | Outperform |
| 05/03/2021 | 118.93% | Morgan Stanley | $15.25 → $18.5 | Maintains | Overweight |
| 04/27/2021 | 124.85% | Raymond James | $20 → $19 | Maintains | Outperform |
| 03/10/2021 | 124.85% | Credit Suisse | $17 → $19 | Maintains | Outperform |
| 02/26/2021 | 136.69% | Raymond James | $18 → $20 | Maintains | Outperform |
| 01/25/2021 | 83.43% | Goldman Sachs | → $15.5 | Initiates Coverage On | → Neutral |
| 01/04/2021 | 80.47% | Morgan Stanley | $14 → $15.25 | Maintains | Overweight |
| 11/17/2020 | 101.18% | Credit Suisse | $14 → $17 | Maintains | Outperform |
| 11/06/2020 | 113.02% | Raymond James | $17 → $18 | Maintains | Outperform |
| 10/22/2020 | 101.18% | Raymond James | $18 → $17 | Maintains | Outperform |
| 09/18/2020 | 113.02% | Raymond James | → $18 | Initiates Coverage On | → Outperform |
| 09/17/2020 | 113.02% | Raymond James | → $18 | Initiates Coverage On | → Outperform |
| 05/15/2020 | 65.68% | Credit Suisse | $17 → $14 | Maintains | Outperform |
| 05/13/2020 | 42.01% | UBS | $24 → $12 | Maintains | Buy |
| 04/09/2020 | 65.68% | Morgan Stanley | $21 → $14 | Maintains | Overweight |
| 04/09/2020 | — | JP Morgan | Downgrades | Overweight → Neutral | |
| 10/18/2019 | 148.52% | B of A Securities | → $21 | Initiates Coverage On | → Neutral |
| 09/12/2019 | 184.02% | JP Morgan | $22 → $24 | Maintains | Overweight |
| 07/11/2019 | — | Compass Point | Initiates Coverage On | → Neutral |
What is the target price for Cushman & Wakefield (CWK)?
The latest price target for Cushman & Wakefield (NYSE: CWK) was reported by UBS on November 22, 2023. The analyst firm set a price target for $9.00 expecting CWK to rise to within 12 months (a possible 6.51% upside). 17 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Cushman & Wakefield (CWK)?
The latest analyst rating for Cushman & Wakefield (NYSE: CWK) was provided by UBS, and Cushman & Wakefield maintained their neutral rating.
When is the next analyst rating going to be posted or updated for Cushman & Wakefield (CWK)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Cushman & Wakefield, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Cushman & Wakefield was filed on November 22, 2023 so you should expect the next rating to be made available sometime around November 22, 2024.
Is the Analyst Rating Cushman & Wakefield (CWK) correct?
While ratings are subjective and will change, the latest Cushman & Wakefield (CWK) rating was a maintained with a price target of $11.00 to $9.00. The current price Cushman & Wakefield (CWK) is trading at is $8.45, which is out of the analyst's predicted range.